Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes (Q33985838)

30 July 2017

title

Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes (English)

1 reference

30 July 2017

6

Robert M Califf

1 reference

30 July 2017

4

Donal N Reddan

1 reference

30 July 2017

Lynda A Szczech

1

1 reference

30 July 2017

Huiman X Barnhart

2

1 reference

30 July 2017

Jula K Inrig

3

1 reference

30 July 2017

Shelly Sapp

5

1 reference

30 July 2017

Uptal D Patel

7

1 reference

30 July 2017

Ajay K Singh

8

1 reference

30 July 2017

language of work or name

English

0 references

publication date

2 July 2008

1 reference

30 July 2017

1 reference

30 July 2017

volume

74

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

791-798

1 reference

Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma.

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

Hematocrit levels and hospitalization risks in hemodialysis patients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

Erythropoietin receptor mRNA expression in human endothelial cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

Risk factors for bacterial infections in chronic haemodialysis adult patients: a multicentre prospective survey.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

Analysis of survival by tumor response.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

Epoetin requirements predict mortality in hemodialysis patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

Administration of parenteral iron and mortality among hemodialysis patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

Influence of relative hypoparathyroidism on the responsiveness to recombinant human erythropoietin in hemodialysis patients.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

Trends in anemia management among US hemodialysis patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902279

IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000

29 October 2018

1 reference

12 December 2020

Iron administration and clinical outcomes in hemodialysis patients

1 reference

12 December 2020

Anemia management in chronic kidney disease: role of factors affecting epoetin responsiveness

1 reference

12 December 2020

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

1 reference

12 December 2020

The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group

1 reference

12 December 2020

Exercise in hemodialysis patients after treatment with recombinant human erythropoietin

1 reference

12 December 2020

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

12 December 2020

Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus

1 reference

12 December 2020

Hematocrit level and associated mortality in hemodialysis patients

1 reference

12 December 2020

Recombinant human erythropoietin: has treatment reached its full potential?

1 reference

12 December 2020

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

12 December 2020

Expression of erythropoietin and erythropoietin receptor in cervical cancer and relationship to survival, hypoxia, and apoptosis

1 reference

12 December 2020

The normal hematocrit study--follow-up

1 reference

12 December 2020

Identifiers

DOI

10.1038/KI.2008.295

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference